Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sterol Regulatory Element-Binding Protein 2 (SREBP2) is a transcription factor that primarily regulates genes involved in cholesterol biosynthesis and uptake. It is anchored to the endoplasmic reticulum when intracellular cholesterol levels are high and is released and activated when cholesterol levels decrease. Upon activation, SREBP2 is cleaved by site-1 protease (S1P) and site-2 protease (S2P), releasing the NH2-terminal fragment (nSREBP2), which then translocates to the nucleus to activate target genes. Variants of the SREBF2 gene have been associated with an increased risk of knee osteoarthritis, and SREBP2 is being explored as a potential target for therapies related to lipid metabolism disorders, such as non-alcoholic steatohepatitis (NASH).
Modulation of cholesterol and fatty acid metabolism
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sterol Regulatory Element-Binding Protein 2 (SREBP2).